KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash & Current Investments (2016 - 2026)

Supernus Pharmaceuticals has reported Cash & Current Investments over the past 15 years, most recently at $308.7 million for Q4 2025.

  • Quarterly Cash & Current Investments fell 31.95% to $308.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $308.7 million through Dec 2025, down 31.95% year-over-year, with the annual reading at $308.7 million for FY2025, 31.95% down from the prior year.
  • Cash & Current Investments was $308.7 million for Q4 2025 at Supernus Pharmaceuticals, up from $281.2 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $522.6 million in Q2 2025 and troughed at $151.7 million in Q2 2023.
  • The 5-year median for Cash & Current Investments is $354.0 million (2022), against an average of $351.2 million.
  • Year-over-year, Cash & Current Investments tumbled 57.97% in 2023 and then surged 128.93% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $339.7 million in 2021, then skyrocketed by 35.81% to $461.3 million in 2022, then tumbled by 44.75% to $254.9 million in 2023, then soared by 77.97% to $453.6 million in 2024, then plummeted by 31.95% to $308.7 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Cash & Current Investments are $308.7 million (Q4 2025), $281.2 million (Q3 2025), and $522.6 million (Q2 2025).